期刊论文详细信息
| JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 卷:91 |
| JAAD Game Changers: Dupilumab shows long-term safety and efficacy in patients with moderate-to-severe atopic dermatitis enrolled in a phase 3 open-label extension study | |
| Editorial Material | |
| Wohltmann, Wendi E.1  | |
| [1] San Antonio Mil Med Ctr, Dermatol & Pathol, 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 USA | |
| DOI : 10.1016/j.jaad.2019.07.074 | |
| 来源: Elsevier | |
PDF
|
|
PDF